These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 2265782

  • 1. Effects of lactulose and lactitol on protein digestion and metabolism in conventional and germ free animal models: relevance of the results to their use in the treatment of portosystemic encephalopathy.
    Bird SP, Hewitt D, Ratcliffe B, Gurr MI.
    Gut; 1990 Dec; 31(12):1403-6. PubMed ID: 2265782
    [Abstract] [Full Text] [Related]

  • 2. The effect of lactulose and lactitol administration on fecal fat excretion in patients with liver cirrhosis.
    Merli M, Caschera M, Piat C, Pinto G, Diofebi M, Riggio O.
    J Clin Gastroenterol; 1992 Sep; 15(2):125-7. PubMed ID: 1401823
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of lactulose and lactitol on colonic microflora and enzymatic activity.
    Ballongue J, Schumann C, Quignon P.
    Scand J Gastroenterol Suppl; 1997 Sep; 222():41-4. PubMed ID: 9145445
    [Abstract] [Full Text] [Related]

  • 6. Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients.
    Riggio O, Varriale M, Testore GP, Di Rosa R, Di Rosa E, Merli M, Romiti A, Candiani C, Capocaccia L.
    J Clin Gastroenterol; 1990 Aug; 12(4):433-6. PubMed ID: 2398251
    [Abstract] [Full Text] [Related]

  • 7. Lactitol in the treatment of chronic hepatic encephalopathy--a randomized cross-over comparison with lactulose.
    Riggio O, Balducci G, Ariosto F, Merli M, Tremiterra S, Ziparo V, Capocaccia L.
    Hepatogastroenterology; 1990 Oct; 37(5):524-7. PubMed ID: 2253931
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of porto-systemic encephalopathy with lactitol verus lactulose: a randomized controlled study.
    Pai CH, Huang YS, Jeng WC, Chan CY, Lee SD.
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jan; 55(1):31-6. PubMed ID: 7712392
    [Abstract] [Full Text] [Related]

  • 10. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
    Gluud LL, Vilstrup H, Morgan MY.
    Cochrane Database Syst Rev; 2016 Apr 18; 4():CD003044. PubMed ID: 27089005
    [Abstract] [Full Text] [Related]

  • 11. Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial.
    Morgan MY, Hawley KE.
    Hepatology; 1987 Apr 18; 7(6):1278-84. PubMed ID: 3315932
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose.
    Lanthier PL, Morgan MY.
    Gut; 1985 Apr 18; 26(4):415-20. PubMed ID: 3979914
    [Abstract] [Full Text] [Related]

  • 14. [The effect of lactitol (NS-4) on the concentrations of ammonia and amino acids in blood and cerebrospinal fluid in Eck fistula (portacaval-shunted) dogs].
    Watanabe M, Ozaki T, Hirata Y, Yoshikuni Y, Kimura K, Suzuki K, Sato S.
    Nihon Yakurigaku Zasshi; 1995 May 18; 105(5):389-402. PubMed ID: 7628787
    [Abstract] [Full Text] [Related]

  • 15. Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study.
    Morgan MY, Hawley KE, Stambuk D.
    J Hepatol; 1987 Apr 18; 4(2):236-44. PubMed ID: 3295020
    [Abstract] [Full Text] [Related]

  • 16. Lactitol versus lactulose in the treatment of acute portal systemic encephalopathy (PSE). A controlled trial.
    Heredia D, Caballería J, Arroyo V, Ravelli G, Rodés J.
    J Hepatol; 1987 Jun 18; 4(3):293-8. PubMed ID: 3598162
    [Abstract] [Full Text] [Related]

  • 17. [1st use of lactitol in the treatment of porto-systemic encephalopathy].
    Bircher J, Bührer M, Franz K, van Velthuijsen JA.
    Schweiz Med Wochenschr; 1982 Sep 18; 112(38):1306-7. PubMed ID: 7134954
    [Abstract] [Full Text] [Related]

  • 18. [Lactitol suppresses the disturbance of consciousness caused by experimentally induced hepatic encephalopathy in rats: an EEG study].
    Mushiroi T, Shibahara R, Ukai Y, Hirata Y, Ozaki T, Watanabe M, Kimura K.
    Nihon Yakurigaku Zasshi; 1995 Feb 18; 105(2):111-9. PubMed ID: 7737591
    [Abstract] [Full Text] [Related]

  • 19. [Lactitol and neomycin: monotherapy or combined therapy in the prevention and treatment of hepatic encephalopathy?].
    Scevola D, Zambelli A, Concia E, Perversi L, Candiani C.
    Clin Ter; 1989 Apr 30; 129(2):105-11. PubMed ID: 2525995
    [Abstract] [Full Text] [Related]

  • 20. Influence of the substrate on the reproducibility of the hydrogen breath test to measure the orocecal transit time.
    Casellas F, Malagelada J.
    Digestion; 1998 Apr 30; 59(6):696-702. PubMed ID: 9813396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.